Home
Biocon Limited
Press Release Apr 21 2026
Business
Apr 21 2026
4 min read

Press Release Apr 21 2026

Biocon Limited has informed the Exchange regarding a press release dated April 21, 2026, titled "Biocon Receives Health Canada Approval of Bosaya (Denosumab) and Vevzuo (Denosumab), Biosimilars to Prolia® and Xgeva®".

View Attachment